Skip to content

A study to evaluate the effect of granisetron in diminishing blood pressure fall after spinal anaesthesia in caesarean patients

Role of granisetron in attenuating hypotension following spinal anaesthesia in elective caesarean section patients: A randomized double-blind study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/041490
Enrollment
70
Registered
2022-03-30
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 1- Obstetrics Health Condition 2: 1- Obstetrics Health Condition 3: 1- Obstetrics Health Condition 4: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: Granisetron: Intravenous Granisetron 1 milligram injected over one minute. Patients will receive the allocated solution intravenously 5 minutes before spinal anaesthesia. Control Inter

Sponsors

Dr Jagannath Mishra
Lead Sponsor
Dr Amiya Kumar Nayak
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Obstetric patients of American society of Anaesthesiology physical status I/II, between 18 and 40 years of age, at 37-42weeks of gestation and undergoing an elective, lower segment caesarean section (CS) for singleton pregnency are included

Exclusion criteria

Exclusion criteria: Parturients not willing to participate in this study Presence of any contraindication for spinal anaesthesia History of allergy to study drug Patients on selective serotonin reuptake inhibitors or migraine medications Ischemic heart disease cardiac insufficiency Diabetes melliutus chronic hypertension Pregnancy induced hypertension Placenta previa Abnormal fetal development Body mass index >35kg/ sq mt Height Patients with pre-existing QT prolongation or any cardiac conduction abnormality

Design outcomes

Primary

MeasureTime frame
attenuation of hypotensionTimepoint: within 45 minutes of administering spinal anaesthesia

Secondary

MeasureTime frame
prevention of bradycardiaTimepoint: within 1 hour of administering spinal anaesthesia

Countries

India

Contacts

Public ContactDr JAGANNATH MISHRA

PRM Medical college and Hospital

jagannathmish@gmail.com8280444000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026